Literature DB >> 26336541

Magnetic resonance imaging of the left atrial appendage post pulmonary vein isolation: Implications for percutaneous left atrial appendage occlusion.

Sheldon M Singh1, Laura Jimenez-Juan2, Asaf Danon1, Gorka Bastarrika2, Andriy V Shmatukha3, Graham A Wright4, Eugene Crystal1.   

Abstract

BACKGROUND: There is increasing interest in performing left atrial appendage (LAA) occlusion at the time of atrial fibrillation (AF) ablation procedures. However, to date there has been no description of the acute changes to the LAA immediately following pulmonary vein (PV) isolation and additional left atrium (LA) substrate modification. This study assessed changes in the size and tissue characteristics of the LAA ostium in patients undergoing PV isolation.
METHODS: This series included 8 patients who underwent cardiovascular magnetic resonance evaluation of the LA with delayed enhancement magnetic resonance imaging and contrast enhanced 3-D magnetic resonance angiography pre-, within 48 h of, and 3 months post ablation. Two independent cardiac radiologists evaluated the ostial LAA diameters and area at each time point in addition to the presence of gadolinium enhancement.
RESULTS: Compared to pre-ablation values, the respective median differences in oblique diameters and LAA area were +1.8 mm, +1.7 mm, and +0.6 cm(2) immediately post ablation (all NS) and -2.7 mm, -2.3 mm, and -0.5 cm(2) at 3 months (all NS). No delayed enhancement was detected in the LAA post ablation.
CONCLUSION: No significant change to LAA diameter, area, or tissue characteristics was noted after PV isolation. While these findings suggest the safety and feasibility of concomitant PV isolation and LAA device occlusion, the variability in the degree and direction of change of the LAA measurements highlights the need for further study.

Entities:  

Keywords:  AF, atrial fibrillation; Atrial fibrillation; CE-3D MRA, contrast enhanced 3-dimensional magnetic resonance angiography; CMR, cardiovascular magnetic resonance imaging; Catheter ablation; DE-MRI, delayed enhancement magnetic resonance imaging; FOV, field of view; IR, inversion recovery; LA, left atrium; LAA, left atrial appendage; Left atrial appendage occlusion; Magnetic resonance imaging; NEX, number of excitations; PV, pulmonary vein; RF, radiofrequency; TE, echo time; TR, repetition time

Year:  2014        PMID: 26336541      PMCID: PMC4550107          DOI: 10.1016/j.joa.2014.08.005

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  23 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI.

Authors:  Ravi Ranjan; Ritsushi Kato; Menekhem M Zviman; Timm M Dickfeld; Ariel Roguin; Ronald D Berger; Gordon F Tomaselli; Henry R Halperin
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-04-14

3.  Impact of the maze procedure on the stroke rate in patients with atrial fibrillation.

Authors:  J L Cox; N Ad; T Palazzo
Journal:  J Thorac Cardiovasc Surg       Date:  1999-11       Impact factor: 5.209

4.  Freedom from atrial arrhythmias after classic maze III surgery: a 10-year experience.

Authors:  Philippe K E W Ballaux; Guillaume S C Geuzebroek; Norbert M van Hemel; Johannes C Kelder; Karl M E Dossche; Jef M P G Ernst; Lukas V A Boersma; Eric F D Wever; Aart Brutel de la Rivière; Jo J A M T Defauw
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

5.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

6.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

7.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

8.  Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation?

Authors:  Vivek Y Reddy; Petr Neuzil; Andre d'Avila; Margaret Laragy; Zachary J Malchano; Stepan Kralovec; Steven J Kim; Jeremy N Ruskin
Journal:  Heart Rhythm       Date:  2007-11-07       Impact factor: 6.343

Review 9.  Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.

Authors:  Hugh Calkins; Matthew R Reynolds; Peter Spector; Manu Sondhi; Yingxin Xu; Amber Martin; Catherine J Williams; Isabella Sledge
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06-02

Review 10.  Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis.

Authors:  Victoria L Baczek; Wendy T Chen; Jeffrey Kluger; Craig I Coleman
Journal:  BMC Fam Pract       Date:  2012-02-03       Impact factor: 2.497

View more
  2 in total

Review 1.  Effect of catheter ablation combined with left appendage occlusion for non-valvular atrial fibrillation: a meta-analysis.

Authors:  Jun Qu; Zhen Wang; Shuhao Wang
Journal:  J Cardiothorac Surg       Date:  2022-05-31       Impact factor: 1.522

2.  Simultaneous Functional and Morphological Assessment of Left Atrial Appendage by 3D Virtual Models.

Authors:  Giorgia Vivoli; Emanuele Gasparotti; Marco Rezzaghi; Elisa Cerone; Massimiliano Mariani; Luigi Landini; Sergio Berti; Vincenzo Positano; Simona Celi
Journal:  J Healthc Eng       Date:  2019-05-21       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.